Unknown

Dataset Information

0

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex.


ABSTRACT: Systematic interrogation of gene function requires the ability to perturb gene expression in a robust and generalizable manner. Here we describe structure-guided engineering of a CRISPR-Cas9 complex to mediate efficient transcriptional activation at endogenous genomic loci. We used these engineered Cas9 activation complexes to investigate single-guide RNA (sgRNA) targeting rules for effective transcriptional activation, to demonstrate multiplexed activation of ten genes simultaneously, and to upregulate long intergenic non-coding RNA (lincRNA) transcripts. We also synthesized a library consisting of 70,290 guides targeting all human RefSeq coding isoforms to screen for genes that, upon activation, confer resistance to a BRAF inhibitor. The top hits included genes previously shown to be able to confer resistance, and novel candidates were validated using individual sgRNA and complementary DNA overexpression. A gene expression signature based on the top screening hits correlated with markers of BRAF inhibitor resistance in cell lines and patient-derived samples. These results collectively demonstrate the potential of Cas9-based activators as a powerful genetic perturbation technology.

SUBMITTER: Konermann S 

PROVIDER: S-EPMC4420636 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC7491238 | BioStudies
2018-01-01 | S-EPMC6508564 | BioStudies
2018-01-01 | S-EPMC5982833 | BioStudies
2017-01-01 | S-EPMC5743067 | BioStudies
2016-01-01 | S-EPMC5016932 | BioStudies
2013-01-01 | S-EPMC3814374 | BioStudies
1000-01-01 | S-EPMC4199701 | BioStudies
1000-01-01 | S-EPMC6348769 | BioStudies
2016-01-01 | S-EPMC4785396 | BioStudies
2013-01-01 | S-EPMC3818127 | BioStudies